Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders
Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders
复制标题
DOI:
10.3390/pharmaceutics12121230
复制
发表时间:
2020-12-18
期刊:
影响因子:
5.4
通讯作者:
Pathak K
中科院分区:
文献类型:
--
作者:
Bahadur S;Pardhi DM;Rautio J;Rosenholm JM;Pathak K
The treatment of various central nervous system (CNS) diseases has been challenging, despite the rapid development of several novel treatment approaches. The blood–brain barrier (BBB) is one of the major issues in the treatment of CNS diseases, having major role in the protection of the brain but simultaneously constituting the main limiting hurdle for drugs targeting the brain. Nasal drug delivery has gained significant interest for brain targeting over the past decades, wherein the drug is directly delivered to the brain by the trigeminal and olfactory pathway. Various novel and promising formulation approaches have been explored for drug targeting to the brain by nasal administration. Nanoemulsions have the potential to avoid problems, including low solubility, poor bioavailability, slow onset of action, and enzymatic degradation. The present review highlights research scenarios of nanoemulsions for nose-to-brain delivery for the management of CNS ailments classified on the basis of brain disorders and further identifies the areas that remain unexplored. The significance of the total dose delivered to the target region, biodistribution studies, and long-term toxicity studies have been identified as the key areas of future research.
登录
查看更多内容
影响因子:
6.7
作者:
Choi KY;Liu G;Lee S;Chen X
通讯作者:
Chen X
影响因子:
3.3
作者:
Boche, Mithila;Pokharkar, Varsha
通讯作者:
Pokharkar, Varsha
影响因子:
3.3
作者:
Azeem, Adnan;Rizwan, Mohammad;Talegaonkar, Sushama
通讯作者:
Talegaonkar, Sushama
影响因子:
2.7
作者:
Abdel-Bar, Hend Mohamed;Abdel-Reheem, Amal Youssef;Mortada, Nahed Daoud
通讯作者:
Mortada, Nahed Daoud
影响因子:
5
作者:
Al-Majed, Abdulhakeem A.;Al-Omar, Fadhel A.;Nagi, Mahmoud N.
通讯作者:
Nagi, Mahmoud N.